Moderna in bid to double COVID-19 vaccine production to up to 3 billion doses in 2022

The U.S. biotech also raised its manufacturing forecast for 2021 to 800 million to 1 billion doses.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.